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ABSTRACT
This study analysed the time-trends for bacteria
associated with nosocomial lower respiratory
tract infections (LRTIs), bloodstream infections
(BSIs) and urinary tract infections (UTIs) that
were reported to the German Nosocomial Infec-
tion Surveillance System for intensive care units
(ICUs). Data concerning 19 822 nosocomial infec-
tions were submitted by 139 ICUs between 2000
and 2005. There was a significant increase in the
proportion of Gram-negative bacteria causing
LRTIs (from 63.9% to 68.4%) and UTIs (from
65.3% to 68.6%). The proportion of BSIs caused
by Gram-negative bacteria declined significantly,
from 36.4% to 22.7%. The frequency of methicil-
lin-resistant Staphylococcus aureus among all
S. aureus isolates increased from 19.8% to 37.2%.
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Knowledge concerning the distribution of bacteria
as causative agents of infections, together with
their resistance patterns, is essential for selecting
appropriate empirical antibiotic treatment.
Although the microbial aetiologies of nosocomial
infections (NIs) are known to differ among hospi-
tals, or even among departments of the same
hospital [1,2], new developments in healthcare
systems and new treatment strategies might affect
the distribution of bacterial pathogens on a wider
level. Changes in the distribution of bacterial
species, as well as increasing resistance rates over
time, have been reported with respect to NIs in the
USA [3]. The aim of the present study was to
investigate the time-trends in bacteria associated
with NIs in intensive care units (ICUs) in Germany
between 2000 and 2005, and to determine the
prevalence of resistance among selected bacterial
pathogens.
The database of the German Surveillance
System for NIs in ICUs (ICU-KISS) was analysed
to determine the distribution of bacteria associ-
ated with nosocomial lower respiratory tract
infections (LRTIs, i.e., pneumonia and bronchitis),
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nosocomial primary bloodstream infections (BSIs)
and nosocomial urinary tract infections (UTIs).
Only data for ICUs that started ICU-KISS surveil-
lance before or during the year 2000, and that
participated continuously until 2005, were used
for this analysis. NIs were defined according to
CDC definitions [4]. Details of the surveillance
methods of ICU-KISS have been described previ-
ously [5,6]. Multidrug resistance of bacteria was
recorded with respect to methicillin resistance
among Staphylococcus aureus and vancomycin
resistance among enterococci.
Temporal changes in the proportions of bacteria
were analysed with the Cochran–Armitage test for
trends, and changes in device usagewere analysed
with theWilcoxon rank sum test for paired samples
of ICU-based data for the years 2000 and 2005. The
analyseswere based ondata from139 continuously
participating ICUs, involving 686 174 patients,
2 464 618 patient-days and 19 822 NIs. Use of
ventilators and central venous catheters remained
constant in these ICUs (42.0 and 70.7 ⁄ 100 patient-
days, respectively), but use of urinary catheters
increased from 77.3 to 81.9 ⁄ 100 patient-days
during the study period. Data concerning
infections during 2000–2005 are summarised in
Table 1.
While the overall proportions of Gram-positive
and Gram-negative bacteria associated with NIs
remained constant, significant changes occurred
within specific types of infection during the study
period (Fig. 1). The majority of pathogens associ-
ated with LRTIs were Gram-negative bacteria,
with a significant increase in the proportion of
these infections associated with Gram-negative
bacteria from 63.9% to 68.4%. The species that
contributed significantly to this increase were
Escherichia coli, Enterobacter spp., Serratia spp. and
Stenotrophomonas maltophilia. However, Gram-
negative bacteria accounted for fewer than one-
third of all nosocomial BSIs with bacterial isolates
during the entire study period, and the propor-
tion of Gram-negative isolates decreased signifi-
cantly, from 36.4% in 2000 to 22.7% in 2005. The
corresponding increase in the proportion of
Gram-positive bacteria associated with BSIs was
associated with a highly significant increase in the
proportion of coagulase-negative staphylococci,
from 29.0% to 42.6%. The proportion of Gram-
negative bacteria associated with UTIs increased
significantly during the study period, from 65.3%
to 68.6%.
Analysis of the time-trends of multidrug resis-
tance revealed that the frequency of methicillin-
resistant S. aureus (MRSA) among all S. aureus
isolates nearly doubled during the study period,
from 19.8% to 37.2%. There was a significant
increase in the frequency of MRSA associated
with LRTIs and BSIs, but the frequency of MRSA
associated with UTIs did not show a significant
time-trend. The rate of vancomycin-resistant
enterococci also increased significantly during
the study period, from 1.3% to 3.0%.
Overall, this descriptive analysis of pathogens
associated with NIs in a large sample of 139
German ICUs revealed significant changes in the
proportions of Gram-negative and Gram-positive
bacteria associated with specific NIs, and also in
the antibiotic resistance of selected bacteria, dur-
ing the 6-year period of the study. Although the
overall incidence of NIs in KISS ICUs has declined
over time because of surveillance activities [7,8],
with a concomitant decline in most of the path-
ogen-specific incidence rates, an analysis of the
distribution of bacteria and resistance rates gives
valuable information to guide empirical antibiotic
treatment.
The most significant finding revealed by the
present study was the decrease in the proportion
of Gram-negative bacteria associated with noso-
comial BSIs. A similar decline in Gram-negative
isolates associated with nosocomial BSIs has been
evident in data from the USA [3]. The corre-
sponding increase in Gram-positive bacteria in
the present study was caused mostly by coagu-
lase-negative staphylococci, which were also the
most common pathogens reported in association
with BSIs in KISS ICUs. Similar findings indicat-
ing that Gram-positive bacteria and coagulase-
negative staphylococci are the most common
pathogens isolated from BSIs have been reported
in other studies [9–11].
In contrast to BSIs, the present study revealed a
significant increase in the proportion of Gram-
negative pathogens associated with LRTIs. An
analysis of US data revealed no change in the
percentage of Gram-negative bacteria associated
with nosocomial pneumonia in the 18-year period
until 2003 [3], but reported a proportion of Gram-
negative bacteria associated with pneumonia that
was in the same range as that found in the present
study.
The MRSA rate found in KISS ICUs was still
lower than the pooled mean MRSA rate of 52.9%
94 Clinical Microbiology and Infection, Volume 14 Number 1, January 2008
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 82–96
T
a
b
le
1
.
S
u
m
m
ar
y
o
f
d
at
a
fo
r
in
te
n
si
v
e
ca
re
u
n
it
s
fr
o
m
th
e
G
er
m
an
S
u
rv
ei
ll
an
ce
S
y
st
em
fo
r
N
o
so
co
m
ia
l
In
fe
ct
io
n
s
fo
r
th
e
p
er
io
d
20
00
–2
00
5
In
fe
ct
io
n
ty
p
e
L
o
w
e
r
re
sp
ir
a
to
ry
tr
a
ct
in
fe
ct
io
n
B
lo
o
d
st
re
a
m
in
fe
ct
io
n
U
ri
n
a
ry
tr
a
ct
in
fe
ct
io
n
T
o
ta
l
n
o
so
co
m
ia
l
in
fe
ct
io
n
s
P
e
ri
o
d
⁄y
ea
r
2
0
0
0
–
2
00
5
2
0
0
0
2
0
0
5
p
a
2
0
0
0
–
2
0
0
5
2
0
0
0
2
0
0
5
p
a
2
0
0
0
–
20
0
5
2
0
0
0
2
0
0
5
p
a
2
0
0
0
–
2
00
5
2
0
00
2
0
0
5
p
a
N
u
m
b
er
o
f
n
o
so
co
m
ia
l
in
fe
ct
io
n
s
(N
Is
)
11
05
8
20
40
17
80
31
70
44
5
50
6
55
94
10
17
95
6
19
82
2
35
02
32
42
In
ci
d
en
ce
d
en
si
ty
o
f
N
Is
⁄1
00
0
p
at
ie
n
t-
d
ay
s
4.
49
5.
61
4.
13
1.
29
1.
22
1.
17
2.
27
2.
80
2.
22
8.
04
9.
63
7.
52
N
Is
w
it
h
n
o
p
at
h
o
g
en
s
is
o
la
te
d
13
.7
12
.5
13
.0
0.
31
8
12
.2
15
.1
9.
7
<
0.
00
1
3.
4
3.
2
3.
1
0.
68
9
10
.6
10
.1
9.
6
0.
00
9
N
Is
as
so
ci
at
ed
w
it
h
fu
n
g
i
an
d
⁄o
r
v
ir
u
se
s
o
n
ly
7.
1
7.
5
9.
5
0.
04
6
8.
1
9.
9
9.
9
0.
76
9
16
.2
17
.5
17
.3
0.
64
0
9.
8
10
.7
11
.8
0.
08
0
N
Is
as
so
ci
at
ed
w
it
h
G
P
an
d
⁄o
r
G
N
b
ac
te
ri
a
79
.2
80
.0
77
.5
0.
67
8
79
.7
75
.0
80
.4
0.
00
4
80
.4
79
.3
79
.6
0.
80
2
79
.6
79
.2
78
.6
0.
47
7
N
u
m
b
er
o
f
G
P
an
d
G
N
b
ac
te
ri
al
is
o
la
te
s
12
00
5
23
25
18
51
27
94
37
6
44
4
53
55
96
8
89
4
20
15
4
36
69
31
89
In
ci
d
en
ce
d
en
si
ty
o
f
b
ac
te
ri
a
⁄1
00
0
p
at
ie
n
t-
d
ay
s
4.
87
6.
39
4.
29
1.
13
1.
03
1.
03
2.
17
2.
66
2.
07
8.
18
10
.0
9
7.
39
G
P
b
ac
te
ri
a
36
.0
36
.1
31
.6
0.
00
1
71
.0
63
.6
77
.3
<
0.
00
01
33
.7
34
.7
31
.4
0.
02
6
40
.3
38
.6
37
.9
0.
29
7
S
ta
ph
yl
oc
oc
cu
s
au
re
u
s
22
.1
19
.8
22
.7
0.
00
8
17
.0
17
.6
17
.6
0.
76
8
2.
5
2.
5
1.
8
0.
36
8
16
.2
15
.0
16
.1
0.
18
M
R
S
A
6.
2
3.
8
8.
0
<
0.
00
01
5.
5
3.
7
7.
7
0.
05
6
0.
7
0.
7
0.
9
0.
78
6
4.
7
3.
0
6.
0
<
0.
00
01
M
R
S
A
⁄1
00
S
.
au
re
u
s
28
.1
19
.1
35
.5
<
0.
00
01
32
.5
21
.2
43
.6
0.
04
2
28
.9
29
.2
50
.0
0.
33
5
28
.8
19
.8
37
.2
<
0.
00
01
E
n
te
ro
co
cc
u
s
sp
p
.
6.
0
6.
6
4.
8
<
0.
00
01
14
.2
15
.4
15
.5
0.
95
2
27
.1
26
.9
26
.8
0.
63
4
12
.7
12
.9
12
.5
0.
15
V
R
E
0.
1
0.
1
0.
1
0.
90
8
0.
2
0.
0
0.
9
0.
00
6
0.
2
0.
4
0.
7
0.
28
0.
1
0.
2
0.
4
0.
02
3
V
R
E
⁄1
00
E
n
te
ro
co
cc
u
s
sp
p
.
0.
8
1.
3
2.
2
0.
54
5
1.
5
0.
0
5.
8
0.
00
7
0.
8
1.
5
2.
5
0.
27
6
0.
9
1.
3
3.
0
0.
01
3
C
o
N
S
3.
5
3.
5
2.
0
<
0.
00
01
37
.8
29
.0
42
.6
<
0.
00
01
3.
6
4.
4
2.
6
0.
00
6
8.
3
6.
3
7.
8
0.
11
1
S
tr
ep
to
co
cc
u
s
sp
p
.
4.
4
6.
2
2.
1
<
0.
00
01
2.
0
1.
6
1.
6
0.
62
1
0.
5
0.
9
0.
2
0.
00
9
3.
1
4.
4
1.
5
<
0.
00
01
G
N
b
ac
te
ri
a
64
.0
63
.9
68
.4
0.
00
1
29
.0
36
.4
22
.7
<
0.
00
01
66
.3
65
.3
68
.6
0.
02
6
59
.7
61
.4
62
.1
0.
29
7
E
sc
he
ri
ch
ia
co
li
10
.0
10
.0
11
.9
0.
00
3
4.
6
4.
3
4.
1
0.
60
3
29
.3
26
.3
30
.2
0.
08
8
14
.4
13
.7
16
.0
0.
00
1
P
se
u
do
m
on
as
ae
ru
gi
n
os
a
14
.7
14
.1
14
.5
0.
74
1
4.
8
6.
1
3.
8
0.
06
1
15
.2
16
.3
14
.1
0.
89
3
13
.5
13
.8
12
.9
0.
20
7
K
le
bs
ie
ll
a
sp
p
.
10
.1
10
.0
10
.5
0.
11
5.
2
7.
4
3.
8
0.
13
3
7.
3
7.
3
8.
9
0.
55
4
8.
7
9.
0
9.
1
0.
44
8
E
n
te
ro
ba
ct
er
sp
p
.
8.
2
7.
8
9.
7
0.
03
2
5.
5
9.
6
4.
5
0.
00
1
5.
3
5.
2
6.
5
0.
03
6
7.
1
7.
3
8.
1
0.
19
1
P
ro
te
u
s
sp
p
.
4.
2
4.
2
4.
8
0.
41
1
1.
0
0.
3
1.
1
0.
99
5
5.
3
5.
4
5.
3
0.
78
3
4.
1
4.
1
4.
4
0.
79
4
S
er
ra
ti
a
sp
p
.
3.
2
1.
9
3.
9
<
0.
00
01
1.
9
1.
9
2.
0
1.
00
0
0.
7
1.
0
0.
6
0.
14
9
2.
3
1.
7
2.
7
0.
00
1
A
ci
n
et
ob
ac
te
r
sp
p
.
3.
7
4.
8
2.
6
<
0.
00
01
1.
8
2.
1
0.
7
0.
17
6
0.
7
0.
7
0.
6
0.
73
2
2.
7
3.
4
1.
8
<
0.
00
01
H
ae
m
op
hi
lu
s
sp
p
.
4.
0
5.
1
3.
7
0.
00
8
0.
1
0.
3
0.
2
0.
88
2
0
0
0
2.
4
3.
3
2.
2
0.
00
1
S
te
n
ot
ro
ph
om
on
as
m
al
to
ph
il
ia
2.
6
2.
5
3.
8
0.
02
8
1.
0
1.
6
0.
5
0.
57
0
0.
2
0.
2
0.
2
0.
29
2
1.
7
1.
8
2.
3
0.
09
3
O
th
er
G
N
b
ac
te
ri
a
3.
3
3.
5
3.
0
0.
13
4
3.
1
2.
8
2.
0
0.
46
9
2.
3
2.
9
2.
2
0.
39
7
2.
8
3.
3
2.
6
0.
05
1
A
ll
n
u
m
b
er
s
ar
e
p
er
ce
n
ta
g
es
u
n
le
ss
o
th
er
w
is
e
in
d
ic
at
ed
.
a
C
o
ch
ra
n
–A
rm
it
ag
e
te
st
fo
r
tr
en
d
.
M
R
S
A
,
m
et
h
ic
il
li
n
-r
es
is
ta
n
t
S
.
au
re
u
s;
V
R
E
,
v
an
co
m
y
ci
n
-r
es
is
ta
n
t
en
te
ro
co
cc
i;
C
o
N
S
,
co
ag
u
la
se
-n
eg
at
iv
e
st
ap
h
y
lo
co
cc
i;
G
P
,
G
ra
m
-p
o
si
ti
v
e;
G
N
,
G
ra
m
-n
eg
at
iv
e.
O
th
er
G
N
b
ac
te
ri
a:
C
it
ro
ba
ct
er
sp
p
.,
o
th
er
en
te
ro
b
ac
te
ri
a,
B
u
rk
ho
ld
er
ia
ce
pa
ci
a,
B
ac
te
ro
id
es
sp
p
.,
L
eg
io
n
el
la
sp
p
.,
o
th
er
n
o
n
-f
er
m
en
ti
n
g
b
ac
te
ri
a.
Research Notes 95
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 82–96
reported for the USA in 1998–2004 [12], but the
significant rise in the rate of MRSA isolates
associated with NIs in Germany within this 6-year
period is a cause for concern. This increase was in
accordance with the increase seen in German data
submitted to the EARSS network (http://www/
rivm.nl/earss), although the present data showed
an overall higher level of methicillin resistance,
probably because of the inclusion only of data
from ICUs.
This study has a number of limitations. The
data recorded in the ICU-KISS database are
limited and do not allow a detailed analysis of
the patient population, the diagnostic and treat-
ment procedures in participating ICUs, or the
characteristics of the bacterial isolates and their
antibiograms. In addition, it was not possible to
associate every infection with a single causative
organism, since polymicrobial infections with
more than one pathogen were reported to
the ICU-KISS database. Also, in a few cases,
bacteria that are unlikely to be of aetiological
significance for specific infections were reported.
ACKNOWLEDGEMENTS
No information has been provided by the authors concerning
the existence or absence of conflicting or dual interests.
REFERENCES
1. Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH,
Fraser VJ. Ventilator-associated pneumonia in a multi-
hospital system: differences in microbiology by location.
Infect Control Hosp Epidemiol 2003; 24: 853–858.
2. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Vari-
ations in etiology of ventilator-associated pneumonia
across four treatment sites: implications for antimicrobial
prescribing practices. Am J Respir Crit Care Med 1999; 160:
608–613.
3. Gaynes R, Edwards JR, National Nosocomial Infections
Surveillance System. Overview of nosocomial infections
caused by gram-negative bacilli. Clin Infect Dis 2005; 41:
848–854.
4. Horan TC, Gaynes RP. Surveillance of nosocomial infec-
tions. In: Mayhall CG, ed., Hospital epidemiology and infec-
tion control, 3rd edn. Baltimore: Lippincott Williams &
Wilkins, 2004; 1659–1702.
5. Gastmeier P, Geffers C, Sohr D, Dettenkofer M, Daschner
F, Ru¨den H. Five years working with the German noso-
comial infection surveillance system (Krankenhaus Infek-
tions Surveillance System). Am J Infect Control 2003; 31:
316–321.
6. Gastmeier P, Sohr D, Geffers C, Nassauer A, Daschner F,
Ruden H. Are nosocomial infection rates in intensive care
units useful benchmark parameters? Infection 2000; 28:
346–350.
7. Zuschneid I, Schwab F, Geffers C, Behnke M, Ru¨den H,
Gastmeier P. Trends in ventilator-associated pneumonia
rates within the German nosocomial infection surveillance
system (KISS). Infect Control Hosp Epidemiol 2007; 28:
314–318.
8. Zuschneid I, Schwab F, Geffers C, Ru¨den H, Gastmeier P.
Reducing central venous catheter-associated primary
bloodstream infections in intensive care units is possible:
data from the German nosocomial infection surveillance
system. Infect Control Hosp Epidemiol 2003; 24: 501–505.
9. Warren DK, Zack JE, Elward AM, Cox MJ, Fraser VJ.
Nosocomial primary bloodstream infections in intensive
care unit patients in a nonteaching community medical
center: a 21-month prospective study. Clin Infect Dis 2001;
33: 1329–1335.
10. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel
RP, Edmond MB. Nosocomial bloodstream infections in
US hospitals: analysis of 24,179 cases from a prospective
nationwide surveillance study. Clin Infect Dis 2004; 39:
309–317.
11. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel
RP, Edmond MB. Nosocomial bloodstream infections in
pediatric patients in United States hospitals: epidemiol-
ogy, clinical features and susceptibilities. Pediatr Infect Dis
J 2003; 22: 686–691.
12. National Nosocomial Infections Surveillance System.
National Nosocomial Infections Surveillance (NNIS)
System Report, data summary from January 1992 through
June 2004, issued October 2004. Am J Infect Control 2004; 32:
470–485.
0
20
40
60
80
2000 2001 2002 2003 2004 2005
Year
Pr
op
or
tio
n 
of
 G
ra
m
-n
eg
at
iv
e 
ba
ct
er
ia
l i
so
la
te
s 
 (%
)
LRTI BSI UTI All
Fig. 1. Proportion of Gram-negative bacteria associated
with lower respiratory tract infection (i.e., pneumonia and
bronchitis), primary bloodstream infection, urinary tract
infection and all nosocomial infections.
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